These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24019118)

  • 1. Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells.
    Chimento A; Casaburi I; Rosano C; Avena P; De Luca A; Campana C; Martire E; Santolla MF; Maggiolini M; Pezzi V; Sirianni R
    Mol Nutr Food Res; 2014 Mar; 58(3):478-89. PubMed ID: 24019118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells.
    Lappano R; Rosano C; Santolla MF; Pupo M; De Francesco EM; De Marco P; Ponassi M; Spallarossa A; Ranise A; Maggiolini M
    Curr Cancer Drug Targets; 2012 Jun; 12(5):531-42. PubMed ID: 22414008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
    Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1.
    Li Y; Birnbaumer L; Teng CT
    Mol Endocrinol; 2010 May; 24(5):969-80. PubMed ID: 20211987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
    Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
    Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation.
    Sirianni R; Chimento A; De Luca A; Casaburi I; Rizza P; Onofrio A; Iacopetta D; Puoci F; Andò S; Maggiolini M; Pezzi V
    Mol Nutr Food Res; 2010 Jun; 54(6):833-40. PubMed ID: 20013881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
    Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
    Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
    De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
    Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling.
    Tian J; Wang Y; Zhang X; Ren Q; Li R; Huang Y; Lu H; Chen J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):153. PubMed ID: 29096683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxytyrosol and Oleuropein Inhibit Migration and Invasion of MDA-MB-231 Triple-Negative Breast Cancer Cell via Induction of Autophagy.
    Lu HY; Zhu JS; Zhang Z; Shen WJ; Jiang S; Long YF; Wu B; Ding T; Huan F; Wang SL
    Anticancer Agents Med Chem; 2019; 19(16):1983-1990. PubMed ID: 31333142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
    Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
    Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
    Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
    Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
    Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
    Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells.
    Shan P; Tang B; Xie S; Zhang Z; Fan J; Wei Z; Song C
    J Cell Biochem; 2021 Jan; 122(1):3-15. PubMed ID: 32985706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (6-bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (carbhydraz) acts as a GPER agonist in breast cancer cells.
    Sinicropi MS; Lappano R; Caruso A; Santolla MF; Pisano A; Rosano C; Capasso A; Panno A; Lancelot JC; Rault S; Saturnino C; Maggiolini M
    Curr Top Med Chem; 2015; 15(11):1035-42. PubMed ID: 25786510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro.
    Fan DX; Yang XH; Li YN; Guo L
    Med Sci Monit; 2018 Apr; 24():1936-1947. PubMed ID: 29608013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway.
    Shi D; Li H; Zhang Z; He Y; Chen M; Sun L; Zhao P
    PLoS One; 2022; 17(1):e0262389. PubMed ID: 35061800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
    Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.